Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 10—October 2020
CME ACTIVITY - Synopsis

Healthcare-Associated Legionnaires’ Disease, Europe, 2008−2017

Julien BeautéComments to Author , Diamantis Plachouras, Sven Sandin, Johan Giesecke, and Pär Sparén
Author affiliations: European Centre for Disease Prevention and Control, Stockholm, Sweden (J. Beauté, D. Plachouras); Karolinska Institutet, Stockholm (J. Beauté, S. Sandin, J. Giesecke, P. Sparén); Icahn School of Medicine at Mount Sinai, New York, New York, USA (S. Sandin); Seaver Autism Center for Research and Treatment at Mount Sinai, New York (S. Sandin)

Main Article

Figure 1

Locally acquired cases of Legionnaires’ disease, European Union–European Economic Area, 2008–2017. Not included are data from Croatia, which started reporting Legionnaires’ disease in 2013.

Figure 1. Locally acquired cases of Legionnaires’ disease, European Union–European Economic Area, 2008–2017. Not included are data from Croatia, which started reporting Legionnaires’ disease in 2013.

Main Article

Page created: July 13, 2020
Page updated: September 17, 2020
Page reviewed: September 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external